Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia - Wikidata - wikimedia - TriplyDB

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

http://www.wikidata.org/entity/Q34217328

about

Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.Hormone-sensitive lipase--new roles for an old enzyme.Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis.Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.Characterization of the promoter of human adipocyte hormone-sensitive lipase.Dynamics of human adipose lipid turnover in health and metabolic disease.Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression.The genetics of familial combined hyperlipidaemia.Chemical modulation of glycerolipid signaling and metabolic pathways.Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism.Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels.The acylation-stimulating protein pathway and regulation of postprandial metabolism.Species-specific alternative splicing generates a catalytically inactive form of human hormone-sensitive lipase.Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism.Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

P2860

Q28363810-73096140-6EA3-4CA8-BC4E-EF7F4BAD3A23 Q33308320-B2614DD9-699A-4EC3-9BEB-DA5BCB9DE46D Q33385647-09D2E663-1294-4155-BAF7-7E5AE42CF085 Q34389639-773E3AEC-2221-49B3-A3B7-CCFB3AEF9313 Q34389958-3ED0F9B9-1D15-4E2A-86D2-D6F9E97DD33C Q35630019-1AA9A60D-33A3-4C4E-A278-E245B3E0038C Q35996939-CFBAF39C-F240-4283-83DC-F1643671F753 Q36519838-1C8DB445-FEB3-4FD4-B238-E033FCC6B0DC Q36891404-F6B7A0D8-5001-4A07-82CA-1F5B8E183E7A Q37173672-A179F8F8-460E-48AB-982A-FDA03D2315D4 Q37358494-D6C3FF64-86FA-4351-A426-09C35A4DF9A8 Q37367368-2E28F3C4-D2E8-40DC-A355-3F776E1CBEEB Q37983699-D5CED3B5-99A5-4C13-8E6F-3453903C858F Q38179801-4F186B46-7FAB-4617-99E5-04BD10E1D4F3 Q41003668-05AC5CF2-5149-4DB2-9C39-C3EA05100124 Q41131878-E777F8C1-03A0-4EEF-BCDA-EA3C46956616 Q41491014-6453AF6D-6D1D-469A-AEF2-87DC545C358E Q41571824-2B0F608A-5D58-4340-903A-A2CE4E5F2D65 Q42107083-22390FC2-D65F-451B-A75A-AFB93ABD3C13 Q42511348-0C497058-59FF-49E8-A4AA-006177A20B26 Q53959743-7739106C-83CD-4832-B1D0-FD994CA235A0

P2860

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

http://www.wikidata.org/entity/Q34217328

description

1995 nî lūn-bûn

@nan

1995 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@ast

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@en

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@nl

type

label

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@ast

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@en

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@nl

prefLabel

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@ast

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@en

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@nl

P1433

Q34217328-6325EB09-AAFB-4F8C-B219-3563D8F19AFB

P1476

Q34217328-FC4B3A04-ED9A-4C97-AFE8-477AE0C85B24

P2093

Q34217328-4D9B5D9A-E92A-442F-9CB1-29229621D9CE

Q34217328-8C2A918D-7228-4407-BA26-5DFC45A3DBFA

Q34217328-CE2F62A7-B75E-4310-B264-CEBCA574C8F9

P2860

Q34217328-0192A6B4-E939-4B28-AB10-EDD04959F419

Q34217328-08A3ADB4-68C1-496A-87AB-379FDBDB39B9

Q34217328-13CF9751-21CD-43DC-979A-F72A85590585

Q34217328-287162BD-409C-4470-8F62-C004CFCD0A02

Q34217328-3016B406-DA71-4D33-A6A0-D9E5058D39DD

Q34217328-3416370A-160E-4B05-AC7E-8A677364EA8B

Q34217328-3A12FFD6-078C-467C-8841-5E43F4456FA9

Q34217328-3C3F6E29-2AD6-422B-B998-031ABDDB1885

Q34217328-4F4C266E-0D16-4EC6-AC74-7C5EAA178DAB

Q34217328-518FFC47-FDD4-4979-AF66-B9B4C2E6E5ED

P304

Q34217328-A642EB8E-6E01-4827-8884-01883E4E0B60

P31

Q34217328-EDCA5859-14B3-4D2A-B86E-A13F6579E06A

P356

Q34217328-953DEB18-6D03-4A94-A59A-674EF9098952

P407

Q34217328-5BAD74EE-FF48-4EE8-906D-3F44B7C31813

P433

Q34217328-139F6063-18F5-431A-8BCD-0781BFBF96DA

P478

Q34217328-E7E90771-E5E5-4821-BD43-455E8168F2C7

P50

Q34217328-CCDE0859-A763-4200-AD14-5A402020D074

P577

Q34217328-450A35BC-2CF3-4AF7-9AD1-7F13E9978517

P5875

Q34217328-022BA141-8DED-4520-B0BE-F0D1D43872B1

P698

Q34217328-0CDDAAA3-0953-49CC-8072-3A684E07BDBA

P921

Q34217328-F7A5AEED-D74C-43DC-AF29-DC4662C7878A

P932

Q34217328-5D554E10-997F-455E-9B11-49ACE7A287E8

P356

P1433

Journal of Clinical Investigation

P1476

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

@en

P2093

Angelin B

http://www.w3.org/2001/XMLSchema#string

Arner P

http://www.w3.org/2001/XMLSchema#string

Reynisdottir S

http://www.w3.org/2001/XMLSchema#string

P2860

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

Catecholamine-induced lipolysis in adipose tissue of the elderly.

Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia.

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias

Influences of variation in total energy intake and dietary composition on regulation of fat cell lipolysis in ideal-weight subjects.

Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma

Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells

P304

2161-2169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117905

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Mikael Eriksson

P577

1995-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15461374

http://www.w3.org/2001/XMLSchema#string

P698

7738184

http://www.w3.org/2001/XMLSchema#string

P921

P932

295819

http://www.w3.org/2001/XMLSchema#string